S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation

Journal of Biological Chemistry

Volumn 287, Issue 50, 2012, Pages 42233-42242

  Botelho, Hugo M ^a   Leal, Sónia S ^a   Cardoso, Isabel ^b,c   Yanamandra, Kiran ^d   Morozova Roche, Ludmilla A ^d   Fritz, Günter ^e   Gomes, Cláudio M ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^d UMEÅ UNIVERSITY   (Sweden)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC CONDITIONS; AGGREGATION KINETICS; AGGREGATION PROPENSITY; AGGREGATION PROPERTY; AMYLOID FIBRIL FORMATION; AMYLOID FORMATION; AMYOTROPHIC LATERAL SCLEROSIS; BINDING KINETICS; CELL VIABILITY; COMPUTATIONAL ANALYSIS; CONFORMATIONAL CHANGE; CYTOSKELETAL DYNAMICS; CYTOTOXIC; EF-HAND; FAST PROCESS; FIBRIL FORMATION; FT-IR INVESTIGATION; INHIBITORY EFFECT; LAG PHASE; NEURODEGENERATIVE DISORDERS; NUCLEATION PROCESS; SUPEROXIDES; TIME RESOLVED IMAGING;

AGGREGATES; CALCIUM; CELL PROLIFERATION; ELECTRON MICROSCOPY; KINETICS; NEURODEGENERATIVE DISEASES; OLIGOMERS; OXYGEN;

PROTEINS;

AMYLOID; CALCIUM; CALCYCLIN; COPPER ZINC SUPEROXIDE DISMUTASE; THIOFLAVINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BINDING KINETICS; CELL VIABILITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME REGULATION; HUMAN; HUMAN CELL; MATHEMATICAL COMPUTING; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE;

AMYLOID; AMYOTROPHIC LATERAL SCLEROSIS; CALCIUM; CELL CYCLE PROTEINS; CELL LINE, TUMOR; HUMANS; KINETICS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; S100 PROTEINS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUPEROXIDE DISMUTASE; THIAZOLES;

EID: 84871281215     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.396416     Document Type: Article

References (75)

1. Fritz, G., and Heizmann, C. W. (2004) in Handbook of Metalloproteins (Messerschmidt, A., Huber, R., Poulos, T., and Wieghardt, K., eds), John Wiley & Sons
2. Fritz, G., Botelho, H. M., Morozova-Roche, L. A., and Gomes, C. M. (2010) Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. FEBS J. 277, 4578-4590
3. Botelho, H. M., Koch, M., Fritz, G., and Gomes, C. M. (2009) Metal ions modulate the folding and stability of the tumor suppressor protein S100A2. Febs J. 276, 1776-1786
4. Santamaria-Kisiel, L., Rintala-Dempsey, A. C., and Shaw, G. S. (2006) Cal-cium- dependent and -independent interactions of the S100 protein family. Biochem. J. 396, 201-214 (Pubitemid 43837235)
5. Zimmer, D. B., Wright Sadosky, P., and Weber, D. J. (2003) Molecular mechanisms of S100-target protein interactions. Microsc. Res. Tech. 60, 552-559
6. Yanamandra, K., Alexeyev, O., Zamotin, V., Srivastava, V., Shchukarev, A., Brorsson, A. C., Tartaglia, G. G., Vogl, T., Kayed, R., Wingsle, G., Olsson, J., Dobson, C. M., Bergh, A., Elgh, F., and Morozova-Roche, L. A. (2009) Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PloS one 4, e5562
7. Ano Bom, A. P., Rangel, L. P., Costa, D. C., de Oliveira, G. A., Sanches, D., Braga, C. A., Gava, L. M., Ramos, C. H., Cepeda, A. O., Stumbo, A. C., De Moura Gallo, C. V., Cordeiro, Y., and Silva, J. L. (2012) Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. J. Biol. Chem. 287, 28152-28162
8. Levy, C. B., Stumbo, A. C., Ano Bom, A. P., Portari, E. A., Cordeiro, Y., Carneiro, Y., Silva, J. L., and De Moura-Gallo, C. V. (2011) Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors. Int. J. Biochem. Cell Biol. 43, 60-64
9. Xu, J., Reumers, J., Couceiro, J. R., De Smet, F., Gallardo, R., Rudyak, S., Cornelis, A., Rozenski, J., Zwolinska, A., Marine, J. C., Lambrechts, D., Suh, Y. A., Rousseau, F., and Schymkowitz, J. (2011) Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat. Chem. Biol. 7, 285-295
10. Boom, A., Pochet, R., Authelet, M., Pradier, L., Borghgraef, P., Van Leuven, F., Heizmann, C. W., and Brion, J. P. (2004) Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochim. Biophys. Acta 1742, 161-168 (Pubitemid 39601776)
11. Hoyaux, D., Boom, A., Van den Bosch, L., Belot, N., Martin, J. J., Heizmann, C. W., Kiss, R., and Pochet, R. (2002) S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients. J. Neuropathol. Exp. Neurol. 61, 736-744 (Pubitemid 34851776)
12. Mori, T., Koyama, N., Arendash, G. W., Horikoshi-Sakuraba, Y., Tan, J., and Town, T. (2010) Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia 58, 300-314
13. Roltsch, E., Holcomb, L., Young, K. A., Marks, A., and Zimmer, D. B. (2010) PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation. J. Neuroinflammation 7, 78
14. Marenholz, I., Heizmann, C. W., and Fritz, G. (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322, 1111-1122 (Pubitemid 39164640)
15. Leniak, W., Słomnicki, Ł. P., and Filipek, A. (2009) S100A6, new facts and features. Biochem. Biophys. Res. Commun. 390, 1087-1092
16. Chattopadhyay, M., and Valentine, J. S. (2009) Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxidants Redox Signaling 11, 1603-1614
17. Hoyaux, D., Alao, J., Fuchs, J., Kiss, R., Keller, B., Heizmann, C. W., Pochet, R., and Frermann, D. (2000) S100A6, a calcium- and zinc-binding protein, is overexpressed in SOD1 mutant mice, a model for amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1498, 264-272
18. Ostendorp, T., Leclerc, E., Galichet, A., Koch, M., Demling, N., Weigle, B., Heizmann, C. W., Kroneck, P. M., and Fritz, G. (2007) Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 26, 3868-3878 (Pubitemid 47295872)
19. Ahl, I. M., Lindberg, M. J., and Tibell, L. A. (2004) Coexpression of yeast copper chaperone (yCCS) and CuZn-superoxide dismutases in Escherichia coli yields protein with high copper contents. Protein Exp. Purif. 37, 311-319 (Pubitemid 39187967)
20. Potter, S. Z., Zhu, H., Shaw, B. F., Rodriguez, J. A., Doucette, P. A., Sohn, S. H., Durazo, A., Faull, K. F., Gralla, E. B., Nersissian, A. M., and Valentine, J. S. (2007) Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. J. Am. Chem. Soc. 129, 4575-4583 (Pubitemid 46648756)
21. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
22. Maurer-Stroh, S., Debulpaep, M., Kuemmerer, N., Lopez de la Paz, M., Martins, I. C., Reumers, J., Morris, K. L., Copland, A., Serpell, L., Serrano, L., Schymkowitz, J. W., and Rousseau, F. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods 7, 237-242
23. Tartaglia, G. G., and Vendruscolo, M. (2008) The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 37, 1395-1401
24. Tartaglia, G. G., Pawar, A. P., Campioni, S., Dobson, C. M., Chiti, F., and Vendruscolo, M. (2008) Prediction of aggregation-prone regions in structured proteins. J. Mol. Biol. 380, 425-436
25. Botelho, H. M., Fritz, G., and Gomes, C. M. (2012) Analysis of S100 oligomers and amyloids. Methods Mol. Biol. 849, 373-386
26. Morozova-Roche, L. A., Zurdo, J., Spencer, A., Noppe, W., Receveur, V., Archer, D. B., Joniau, M., and Dobson, C. M. (2000) Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 130, 339-351
27. Barth, A., and Zscherp, C. (2002) What vibrations tell us about proteins. Q. Rev. Biophys. 35, 369-430 (Pubitemid 36207229)
28. Berridge, M. V., Tan, A., S., McCoy, K. D., and Wang, R. (1996) The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochemica 4, 14-19
29. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., Rasool, S., Gurlo, T., Butler, P., and Glabe, C. G. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18
30. Cohen, S. I., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. (2012) From macroscopic measurements to microscopic mechanisms of protein aggregation. J. Mol. Biol. 421, 160-171
31. Goldsbury, C., Frey, P., Olivieri, V., Aebi, U., and Müller, S. A. (2005) Multiple assembly pathways underlie amyloid-β fibril polymorphisms. J. Mol. Biol. 352, 282-298 (Pubitemid 41213315)
32. Green, J. D., Goldsbury, C., Kistler, J., Cooper, G. J., and Aebi, U. (2004) Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J. Biol. Chem. 279, 12206-12212 (Pubitemid 38445785)
33. Cerf, E., Sarroukh, R., Tamamizu-Kato, S., Breydo, L., Derclaye, S., Dufrêne, Y. F., Narayanaswami, V., Goormaghtigh, E., Ruysschaert, J. M., and Raussens, V. (2009) Antiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide. Biochem. J. 421, 415-423
34. Leclerc, E., Fritz, G., Weibel, M., Heizmann, C. W., and Galichet, A. (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 282, 31317-31331 (Pubitemid 350044892)
35. Hoyaux, D., Decaestecker, C., Heizmann, C. W., Vogl, T., Schäfer, B. W., Salmon, I., Kiss, R., and Pochet, R. (2000) S100 proteins in Corpora amylacea from normal human brain. Brain Res. 867, 280-288 (Pubitemid 30317409)
36. Leal, S. S., Botelho, H. M., and Gomes, C. M. (2012) Metal ions as modulators of protein conformation and misfolding in neurodegeneration. Coordination Chem. Rev. 256, 2253-2270
37. Münch, C., O'Brien, J., and Bertolotti, A. (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. U.S.A. 108, 3548-3553
38. Monsellier, E., and Chiti, F. (2007) Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep. 8, 737-742 (Pubitemid 47202452)
39. Rousseau, F., Serrano, L., and Schymkowitz, J. W. (2006) How evolutionary pressure against protein aggregation shaped chaperone specificity. J. Mol. Biol. 355, 1037-1047 (Pubitemid 43012146)
40. Otterbein, L. R., Kordowska, J., Witte-Hoffmann, C., Wang, C. L., and Dominguez, R. (2002) Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution. Structure 10, 557-567 (Pubitemid 34304234)
41. Chiti, F., and Dobson, C. M. (2009) Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 5, 15-22
42. Winningham-Major, F., Staecker, J. L., Barger, S. W., Coats, S., and Van Eldik, L. J. (1989) Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. J. Cell Biol. 109, 3063-3071 (Pubitemid 20011930)
43. Huttunen, H. J., Kuja-Panula, J., Sorci, G., Agneletti, A. L., Donato, R., and Rauvala, H. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105 (Pubitemid 32064635)
44. Kögel, D., Peters, M., König, H. G., Hashemi, S. M., Bui, N. T., Arolt, V., Rothermundt, M., and Prehn, J. H. (2004) S100B potently activates p65/c- Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience 127, 913-920 (Pubitemid 39099556)
45. Baglioni, S., Casamenti, F., Bucciantini, M., Luheshi, L. M., Taddei, N., Chiti, F., Dobson, C. M., and Stefani, M. (2006) Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J. Neurosci. 26, 8160-8167 (Pubitemid 44315140)
46. Fritz, G. (2011) RAGE: a single receptor fits multiple ligands. Trends Biochem. Sci. 36, 625-632
47. Lewis, J., Dickson, D. W., Lin, W. L., Chisholm, L., Corral, A., Jones, G., Yen, S. H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M., and McGowan, E. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491 (Pubitemid 32801551)
48. Götz, J., Chen, F., van Dorpe, J., and Nitsch, R. M. (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Aβ 42 fibrils. Science 293, 1491-1495 (Pubitemid 32807681)
49. Barbato, C., Canu, N., Zambrano, N., Serafino, A., Minopoli, G., Ciotti, M. T., Amadoro, G., Russo, T., and Calissano, P. (2005) Interaction of tau with Fe65 links tau to APP. Neurobiology Disease 18, 399-408 (Pubitemid 40431124)
50. Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., and Calissano, P. (2012) Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration. Neurobiology Aging 33, 833
51. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128-1132
52. Zou, W. Q., Xiao, X., Yuan, J., Puoti, G., Fujioka, H., Wang, X., Richardson, S., Zhou, X., Zou, R., Li, S., Zhu, X., McGeer, P. L., McGeehan, J., Kneale, G., Rincon-Limas, D. E., Fernandez-Funez, P., Lee, H. G., Smith, M. A., Petersen, R. B., and Guo, J. P. (2011) Amyloid-β42 interacts mainly with insoluble prion protein in the Alzheimer brain. J. Biol. Chem. 286, 15095-15105
53. Pflanzner, T., Petsch, B., André-Dohmen, B., Müller- Schiffmann, A., Tschickardt, S., Weggen, S., Stitz, L., Korth, C., and Pietrzik, C. U. (2012) Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier. J. Cerebral Blood Flow Metabolism 32, 628-632
54. Ferrer, I., Blanco, R., Carmona, M., Puig, B., Ribera, R., Rey, M. J., and Ribalta, T. (2001) Prion protein expression in senile plaques in Alzheimer's disease. Acta Neuropathology 101, 49-56 (Pubitemid 32124500)
55. Kovacs, G. G., Zerbi, P., Voigtländer, T., Strohschneider, M., Trabattoni, G., Hainfellner, J. A., and Budka, H. (2002) The prion protein in human neurodegenerative disorders. Neurosci. Letts. 329, 269-272 (Pubitemid 35245339)
56. Kudo, W., Lee, H. P., Zou, W. Q., Wang, X., Perry, G., Zhu, X., Smith, M. A., Petersen, R. B., and Lee, H. G. (2012) Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Hum. Mol. Genet. 21, 1138-1144
57. O'Nuallain, B., Williams, A. D., Westermark, P., and Wetzel, R. (2004) Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279, 17490-17499 (Pubitemid 38560512)
58. Nicolls, M. R. (2004) The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease. Curr. Alzheimer Res. 1, 47-54
59. Rezaei-Ghaleh, N., Andreetto, E., Yan, L. M., Kapurniotu, A., and Zweckstetter, M. (2011) Interaction between amyloid β peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide. PLoS One 6, e20289
60. Yan, L. M., Velkova, A., Tatarek-Nossol, M., Andreetto, E., and Kapurniotu, A. (2007) IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Aβ and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes. Angew Chem. Int. Ed. Engl. 46, 1246-1252 (Pubitemid 46981368)
61. Seeliger, J., Evers, F., Jeworrek, C., Kapoor, S., Weise, K., Andreetto, E., Tolan, M., Kapurniotu, A., and Winter, R. (2012) Cross-amyloid interaction of Aβ and IAPP at lipid membranes. Angew Chem. Int. Ed. Engl. 51, 679-683
62. Andreetto, E., Yan, L. M., Caporale, A., and Kapurniotu, A. (2011) Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity. Chembiochem. 12, 1313-1322
63. Miklossy, J., Qing, H., Radenovic, A., Kis, A., Vileno, B., Laszlo, F., Miller, L., Martins, R. N., Waeber, G., Mooser, V., Bosman, F., Khalili, K., Darbinian, N., and McGeer, P. L. (2010) Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol. Aging 31, 1503-1515
64. Shi, J., Perry, G., Berridge, M. S., Aliev, G., Siedlak, S. L., Smith, M. A., LaManna, J. C., and Friedland, R. P. (2002) Labeling of cerebral amyloid β deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. J. Nuclear Med. 43, 1044-1051 (Pubitemid 34847928)
65. Moss, J., Shore, I., and Woodrow, D. (1994) AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin. Histopathology 24, 427-435 (Pubitemid 24192312)
66. Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, I. M., and Hohenester, E. (1997) Amyloid P component. A critical review. Amyloid 4, 274-295 (Pubitemid 127716144)
67. Zhang, X., and Li, J. P. (2010) Heparan sulfate proteoglycans in amyloidosis. Progr. Mol. Biol. Translat. Sci. 93, 309-334
68. Ancsin, J. B. (2003) Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid 10, 67-79
69. Inoue, S., Kawano, H., Ishihara, T., Maeda, S., and Ohno, S. (2005) Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study. Amyloid 12, 157-163 (Pubitemid 41503220)
70. Holm Nielsen, E., Nybo, M., Junker, K., Toftedal Hansen, P., Rasmussen, I. M., and Svehag, S. E. (2000) Localization of human serum amyloid P component and heparan sulfate proteoglycan in in vitro-formed Aβ fibrils. Scand. J. Immunol. 52, 110-112
71. Bodin, K., Ellmerich, S., Kahan, M. C., Tennent, G. A., Loesch, A., Gilbertson, J. A., Hutchinson, W. L., Mangione, P. P., Gallimore, J. R., Millar, D. J., Minogue, S., Dhillon, A. P., Taylor, G. W., Bradwell, A. R., Petrie, A., Gillmore, J. D., Bellotti, V., Botto, M., Hawkins, P. N., and Pepys, M. B. (2010) Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature 468, 93-97
72. Togashi, S., Lim, S. K., Kawano, H., Ito, S., Ishihara, T., Okada, Y., Nakano, S., Kinoshita, T., Horie, K., Episkopou, V., Gottesman, M. E., Costantini, F., Shimada, K., and Maeda, S. (1997) Serum amyloid P component enhances induction of murine amyloidosis. Lab. Investig. 77, 525-531 (Pubitemid 27508623)
73. Inoue, S., and Kisilevsky, R. (1996) A high resolution ultrastructural study of experimental murine AA amyloid. Lab. Investig. 74, 670-683 (Pubitemid 26105729)
74. Inoue, S., Kuroiwa, M., Tan, R., and Kisilevsky, R. (1998) A high resolution ultrastructural comparison of isolated and in situ murine AA amyloid fibrils. Amyloid 5, 99-110 (Pubitemid 128691226)
75. Kanekiyo, T., Zhang, J., Liu, Q., Liu, C. C., Zhang, L., and Bu, G. (2011) Heparan sulphate proteoglycan and the low-density lipoprotein receptorrelated protein 1 constitute major pathways for neuronal amyloid-β uptake. J. Neurosci. 31, 1644-1651